Mohammed Ullah

Risdiplam distributes and increases <scp>SMN</scp> protein in both the central nervous system and peripheral organs

Agnès Poirier, Marla Weetall, Katja Heinig et al. · Pharmacology Research & Perspectives · 2018 · 169 citations · Full text

Life Sciences, Neuroscience, Pharmacology +15

Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice

Tuancheng Feng, Shuyi Mai, Jenn Marie Roscoe et al. · EMBO Reports · 2020 · 111 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein

Holger Fischer, Mohammed Ullah, Cecile C. de la Cruz et al. · Neuro-Oncology · 2020 · 104 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Minimizing DILI risk in drug discovery — A screening tool for drug candidates

Simone Schadt, Silke Simon, Stefan Kustermann et al. · Toxicology in Vitro · 2015 · 88 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Refining the In Vitro and In Vivo Critical Parameters for P-Glycoprotein, [I]/IC₅₀and [I₂]/IC₅₀, That Allow for the Exclusion of Drug Candidates from Clinical Digoxin Interaction Studies

Jack Cook, Bo Feng, Katherine S. Fenner et al. · Molecular Pharmaceutics · 2009 · 58 citations

Pharmacy, Pharmacokinetics, Pharmacology +16